Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Neurology|February 26, 2003
Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patientsA Bertolotto, F Gilli, A Sala, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 24, 2017
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE studyA Ghezzi, A Bianchi, D Baroncini, et al.Journal of Neurology|July 22, 2021
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout durationD Ferraro, P Iaffaldano, T Guerra, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 7, 2013
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody developmentH Hegen, A Millonig, A Bertolotto, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 29, 2013
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 casesA Ghezzi, P Annovazzi, E Cocco, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 3, 2020
Informing MS patients on treatment options: a consensus on the process of consent takingC Tortorella, C Solaro, P Annovazzi, et al.Pageof 3